Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-8.34 %
$ 70.1 M
Market Cap
0.07
P/E
AVTX - OTHER FINANCING ACTIVITIES
Other Financing Activities AVTX - Avalo Therapeutics, Inc.
67 K
LAST VALUE
-81.38%
2 YEAR CAGR
-60.00%
5 YEAR CAGR
-35.55%
10 YEAR CAGR